There are 2789 resources available
500P - Molecular features in liquid biopsy of early (EO) and late-onset colorectal cancer (LO)
Presenter: Julia Alcaide-Garcia
Session: ePoster Display
501P - Analysis of clinical characteristics and survival trends of patients with metastatic colorectal cancer (mCRC) receiving ≥3 lines of treatment
Presenter: Marianela Bringas Beranek
Session: ePoster Display
502P - Impact of different selection approaches for identifying Lynch syndrome-related colorectal cancer patients
Presenter: Daniele Fanale
Session: ePoster Display
503P - Mutational landscape in synchronous unresectable metastatic colorectal cancer (mCRC) according to upfront primary tumour resection (UPTR)
Presenter: Manuel Benavides
Session: ePoster Display
504P - Prognostic factors of patients with AFP-positive colorectal cancer: A case-control study
Presenter: Min-Yi Lv
Session: ePoster Display
505TiP - REGINA: A phase II trial of neoadjuvant regorafenib (rego) in combination with nivolumab (nivo) and short-course radiotherapy (SCRT) in intermediate-risk, stage II-III rectal cancer (RC)
Presenter: Giacomo Bregni
Session: ePoster Display
506TiP - Pembrolizumab plus lenvatinib versus standard of care for previously treated metastatic colorectal cancer (mCRC): Phase III LEAP-017 study
Presenter: Takayuki Yoshino
Session: ePoster Display
507TiP - PRESERVE 1: A phase III, randomized, double-blind trial of trilaciclib versus placebo in patients receiving FOLFOXIRI/bevacizumab for metastatic colorectal cancer
Presenter: Joleen Hubbard
Session: ePoster Display
509TiP - REPROGRAM-01, a phase II study of regorafenib in combination with a multimodal metronomic chemotherapy in patients with metastatic colorectal cancer
Presenter: Elodie Klajer
Session: ePoster Display